サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1472131

オルガノイドとスフェロイドの世界市場規模調査・予測：タイプ別、方法別、エンドユーザー別、地域別分析（2023年～2030年）

Global Organoids and Spheroids Market Size Study & Forecast, by Type, By Method, By End-User, and Regional Analysis, 2023-2030

出版日
ページ情報
英文 200 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
オルガノイドとスフェロイドの世界市場規模調査・予測：タイプ別、方法別、エンドユーザー別、地域別分析（2023年～2030年）
出版日: 2024年04月13日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のオルガノイドとスフェロイドの市場規模は、2022年に約5億6,051万米ドルに達し、予測期間2023年～2030年に8.5％超の健全な成長率で成長すると予測されています。 オルガノイドとスフェロイドは、再生医療、創薬、疾患モデリングなどの科学研究に広く採用されている高度な3次元（3D）細胞培養モデルです。

オルガノイドは、幹細胞や組織特異的な前駆細胞から発達した複雑で自己組織化的な構造体であり、特定の臓器や組織の構造や機能を忠実に再現しています。このモデルは様々な細胞タイプに由来し、臓器発生、疾病メカニズム、薬物毒性、個別化医療を研究するための微妙なプラットフォームを提供します。一方、スフェロイドは、特定の培養条件下で自発的に球形を形成する細胞集合体です。スフェロイドは、細胞の挙動、薬物応答、腫瘍生物学、多様な細胞種に由来する組織工学の研究に広く役立っています。オルガノイドもスフェロイドも、従来の2次元細胞培養よりも生理学的により適切な環境を研究者に提供し、簡略化されたモデルと複雑なin vivoシステムとの間の重要な架け橋となります。オルガノイドとスフェロイド市場は、個別化治療薬に対する需要の増加、研究開発活動への投資の増加、がん研究のためのオルガノイド3次元細胞培養へのシフトの増加などの要因によって牽引されています。さらに、遺伝子変異解析、遺伝子評価、腫瘍モデリングなど、さまざまな用途でオルガノイド技術の採用が拡大しており、オルガノイドの需要を世界的に押し上げる構えです。

さらに、がん、糖尿病、神経疾患などの慢性疾患の有病率の増加も、世界全体の市場成長にプラスの影響を及ぼしています。高度な3Dモデルであるオルガノイドやスフェロイドは、ヒトの組織構造を忠実に模倣しているため、精密な疾患研究や治療試験が可能です。薬剤に対する患者固有の反応を分析することで、個別化医療の開発を促進します。2021年4月に発表された世界保健機関（WHO）のデータによると、慢性疾患により毎年4,100万人が死亡すると予想されており、これは世界全体の死亡者数の71％に相当します。低・中所得国では、慢性疾患による死亡が77％を占めます。さらに、これらのモデルは創薬プロセスを合理化し、疾患経路に関する洞察を提供し、治療標的の同定を助けます。さらに、組織工学と再生医療において、オルガノイドとスフェロイドは、慢性疾患によって引き起こされる臓器の損傷に対処するための機能的組織代替物の開発に有望です。全体として、慢性疾患の罹患率の増加は、疾患解明と治療開発の進展におけるオルガノイドとスフェロイドの重要性を強調しています。さらに、細胞治療と組織工学分野の成長と、3Dスフェロイド技術の技術的進歩の増加は、予測される数年間にさまざまな有利な機会をもたらします。しかし、3D細胞培養に関連する課題やオルガノイドとスフェロイド培養に関連する倫理的問題が、2023年～2030年の予測期間を通じて市場成長の妨げとなっています。

オルガノイドとスフェロイドの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、製薬会社やバイオテクノロジー企業による技術進歩の増加、バイオ医薬品の研究開発への注目の高まり、医薬品の生産と創薬の急増により、2022年の市場を独占しました。一方、アジア太平洋は予測期間中に最も高いCAGRで成長すると予想されています。3D細胞培養技術の進歩、ヘルスケア支出の増加、幹細胞研究の継続的な進歩が、同地域全体の市場需要を大きく押し上げています。主要市場企業間の協力関係の増加が市場拡大を後押しすると予測されています。例えば、2020年3月にニチレイバイオサイエンシズとUPMバイオメディカルズが提携し、UPMの培養製品を日本で提供することで、スフェロイドやオルガノイド培養用の天然ハイドロゲルへのアクセスが向上しています。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も掲載しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界のオルガノイドとスフェロイド市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 世界のオルガノイドとスフェロイド市場力学

  • オルガノイドとスフェロイド市場の影響分析（2020年～2030年）
    • 市場促進要因
      • 慢性疾患の増加
      • 個別化医療の採用増加
    • 市場の課題
      • 3D細胞培養に伴う課題
      • オルガノイドとスフェロイド培養に伴う倫理的問題
    • 市場機会
      • 細胞治療および組織工学分野の成長
      • 3Dスフェロイド技術における技術進歩の増加

第4章 世界のオルガノイドとスフェロイド市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターのファイブフォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 オルガノイドとスフェロイドの世界市場：タイプ別

  • 市場スナップショット
  • オルガノイドとスフェロイドの世界市場：タイプ別、実績 - ポテンシャル分析
  • オルガノイドとスフェロイドの世界市場：タイプ別、推定・予測（2020年～2030年）
  • オルガノイドとスフェロイド市場：サブセグメント分析
    • オルガノイドタイプ
    • スフェロイドタイプ

第6章 オルガノイドとスフェロイドの世界市場：方法別

  • 市場スナップショット
  • オルガノイドとスフェロイドの世界市場：方法別、実績 - ポテンシャル分析
  • オルガノイドとスフェロイドの世界市場、方法別、推定・予測（2020年～2030年）
  • オルガノイドとスフェロイド市場：サブセグメント分析
    • 細胞外マトリックス足場法
    • スピニング・バイオリアクター法
    • ハンギングドロップ法
    • 低付着性培養プレート法
    • 磁気浮上法

第7章 オルガノイドとスフェロイド市場：エンドユーザー別

  • 市場スナップショット
  • オルガノイドとスフェロイドの世界市場：エンドユーザー別、実績 - ポテンシャル分析
  • オルガノイドとスフェロイドの世界市場：エンドユーザー別、推定・予測（2020年～2030年）
  • オルガノイドとスフェロイド市場：サブセグメント分析
    • バイオテクノロジーおよび製薬産業
    • 学術・研究機関
    • 病院・診断センター

第8章 オルガノイドとスフェロイドの世界市場：地域別分析

  • 主要国
  • 主要新興国
  • オルガノイドとスフェロイド市場：地域別市場スナップショット
  • 北米
    • 米国
      • タイプの推定・予測（2020年～2030年）
      • 方法の推定・予測（2020年～2030年）
      • エンドユーザーの推定・予測（2020年～2030年）
    • カナダ
  • 欧州のオルガノイドとスフェロイド市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋のオルガノイドとスフェロイド市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカのオルガノイドとスフェロイド市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東・アフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • InSphero AG
    • Lonza Group
    • PeproTech Inc
    • Greiner AG
    • STEMCELL Technologies Inc
    • Corning Inc
    • Cellesce Ltd
    • Perkin Elmer Inc
    • Merck KGaA
    • Thermofisher Scientific Inc

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1.Global Organoids and Spheroids Market, report scope
  • TABLE 2.Global Organoids and Spheroids Market estimates & forecasts by Region 2020-2030 (USD Million)
  • TABLE 3.Global Organoids and Spheroids Market estimates & forecasts by Type 2020-2030 (USD Million)
  • TABLE 4.Global Organoids and Spheroids Market estimates & forecasts by Method 2020-2030 (USD Million)
  • TABLE 5.Global Organoids and Spheroids Market estimates & forecasts by End-user 2020-2030 (USD Million)
  • TABLE 6.Global Organoids and Spheroids Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 7.Global Organoids and Spheroids Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 8.Global Organoids and Spheroids Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 9.Global Organoids and Spheroids Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 10.Global Organoids and Spheroids Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 11.Global Organoids and Spheroids Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 12.Global Organoids and Spheroids Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 13.Global Organoids and Spheroids Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 14.Global Organoids and Spheroids Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 15.Global Organoids and Spheroids Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 16.U.S. Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 17.U.S. Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 18.U.S. Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 19.Canada Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 20.Canada Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 21.Canada Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 22.UK Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 23.UK Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 24.UK Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 25.Germany Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 26.Germany Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 27.Germany Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 28.France Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 29.France Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 30.France Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 31.Italy Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 32.Italy Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 33.Italy Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 34.Spain Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 35.Spain Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 36.Spain Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 37.RoE Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 38.RoE Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 39.RoE Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 40.China Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 41.China Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 42.China Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 43.India Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 44.India Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 45.India Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 46.Japan Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 47.Japan Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 48.Japan Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 49.South Korea Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 50.South Korea Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 51.South Korea Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 52.Australia Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 53.Australia Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 54.Australia Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 55.RoAPAC Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 56.RoAPAC Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 57.RoAPAC Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 58.Brazil Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 59.Brazil Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 60.Brazil Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 61.Mexico Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 62.Mexico Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 63.Mexico Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 64.RoLA Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 65.RoLA Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 66.RoLA Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 67.Saudi Arabia Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 68.South Africa Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 69.RoMEA Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 70.List of secondary sources, used in the study of global Organoids and Spheroids Market
  • TABLE 71.List of primary sources, used in the study of global Organoids and Spheroids Market
  • TABLE 72.Years considered for the study
  • TABLE 73.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1.Global Organoids and Spheroids Market, research methodology
  • FIG 2.Global Organoids and Spheroids Market, Market estimation techniques
  • FIG 3.Global Market size estimates & forecast methods
  • FIG 4.Global Organoids and Spheroids Market, key trends 2022
  • FIG 5.Global Organoids and Spheroids Market, growth prospects 2023-2030
  • FIG 6.Global Organoids and Spheroids Market, porters 5 force model
  • FIG 7.Global Organoids and Spheroids Market, pest analysis
  • FIG 8.Global Organoids and Spheroids Market, value chain analysis
  • FIG 9.Global Organoids and Spheroids Market by segment, 2020 & 2030 (USD Million)
  • FIG 10.Global Organoids and Spheroids Market by segment, 2020 & 2030 (USD Million)
  • FIG 11.Global Organoids and Spheroids Market by segment, 2020 & 2030 (USD Million)
  • FIG 12.Global Organoids and Spheroids Market by segment, 2020 & 2030 (USD Million)
  • FIG 13.Global Organoids and Spheroids Market by segment, 2020 & 2030 (USD Million)
  • FIG 14.Global Organoids and Spheroids Market, regional snapshot 2020 & 2030
  • FIG 15.North America Organoids and Spheroids Market 2020 & 2030 (USD Million)
  • FIG 16.Europe Organoids and Spheroids Market 2020 & 2030 (USD Million)
  • FIG 17.Asia Pacific Organoids and Spheroids Market 2020 & 2030 (USD Million)
  • FIG 18.Latin America Organoids and Spheroids Market 2020 & 2030 (USD Million)
  • FIG 19.Middle East & Africa Organoids and Spheroids Market 2020 & 2030 (USD Million)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Organoids and Spheroids Market is valued at approximately USD 560.51 million in 2022 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2023-2030. Organoids and spheroids represent advanced three-dimensional (3D) cell culture models extensively employed in scientific research, spanning regenerative medicine, drug discovery, and disease modelling domains. Organoids are complex and self-organizing structures that are developed from stem cells or tissue-specific progenitor cells, closely replicating the architecture and functionality of specific organs or tissues. This model is derived from various cell types and provides a nuanced platform for investigating organ development, disease mechanisms, drug toxicity, and personalized medicine. Whereas spheroids are cell aggregates that spontaneously form spherical shapes under specific culture conditions. Spheroids are instrumental in studying cell behaviour, drug responses, tumour biology, and tissue engineering widely derived from diverse cell types. Both organoids and spheroids offer researchers more physiologically relevant environments than traditional 2D cell cultures and present as an essential bridge between simplified models and the complexities of in vivo systems. The Organoids and Spheroids Market are being driven by factors including increasing demand for personalized drugs, growing investments in R&D activities, and a rise in the shift towards organoid 3D cell cultures for cancer research. . Furthermore, the expanding adoption of organoid technology across various applications such as genetic mutation analysis, gene assessment, and tumour modelling is poised to propel the demand for organoids globally.

In addition, the increasing prevalence of chronic diseases like cancer, diabetes, and neurological disorders is also exhibiting a positive influence on market growth across the world. Organoids and spheroids, advanced 3D models, closely mimic human tissue structures, enabling precise disease studies and treatment testing. They facilitate personalized medicine development by analyzing patient-specific responses to drugs. According to World Health Organization (WHO) data published in April 2021, chronic diseases are expected to kill 41 million people each year, equivalent to 71% of all deaths globally. In low- and middle-income countries chronic disease death are accounted for 77%. Additionally, these models streamline drug discovery processes and offer insights into disease pathways, aiding in the identification of therapeutic targets. Moreover, in tissue engineering and regenerative medicine, organoids and spheroids hold promise for developing functional tissue substitutes to address organ damage caused by chronic diseases. Overall, the rising incidence of chronic diseases underscores the significance of organoids and spheroids in advancing disease understanding and treatment development. Moreover, the growing field of cell therapy and tissue engineering, as well as the increasing technological advancements in 3D spheroid technologies presents various lucrative opportunities over the forecasting years. However, the challenges associated with 3D cell culturing and ethical issues associated with organoid & spheroid cultures are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Organoids and Spheroids Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing technological advancements by pharmaceutical and biotechnology companies, a rise in focus on biopharmaceutical R&D, as well as surging production of medicines and drug discovery. Whereas Asia Pacific is expected to grow at the highest CAGR over the forecast years. The rise in advancements in 3D cell culture technology, increasing healthcare spending, and ongoing advancements in stem cell research are significantly propelling the market demand across the region. Increasing collaborations among key market players are anticipated to bolster market expansion. For instance, in March 2020, Nichirei Biosciences and UPM Biomedicals joined forces to offer UPM culture products in Japan, thus improving the accessibility of natural hydrogels for spheroid and organoid culture.

Major market players included in this report are:

  • InSphero AG
  • Lonza Group
  • PeproTech Inc.
  • Greiner AG
  • STEMCELL Technologies Inc.
  • Corning Inc.
  • Cellesce Ltd.
  • Perkin Elmer Inc.
  • Merck KGaA
  • Thermofisher Scientific Inc.

Recent Developments in the Market:

  • In August 2023, InSphero, a company renowned for its expertise in robotics and intelligent automation announced a distribution agreement with Advanced BioMatrix, a leading provider of biomaterial solutions for cellular assays and regenerative medicine. The collaboration aims to extend the application of 3D cell culture techniques beyond conventional suspension-based methods, focusing on the incorporation of scaffold-based models.
  • In June 2023, Inventia Life Science formed a strategic partnership with Biotron Healthcare to distribute its RASTRUM miniaturized 3D cell culturing platform across India. This partnership aims to enhance the field of organoids and spheroids by increasing the accessibility of the advanced technology offered by the RASTRUM platform to researchers across India.
  • in June 2023, AMSBIO launched Matrimix, a novel 3D cell culture substrate featuring a fully defined formulation and it enables researchers to grow a range of tissues. It offers a dependable and constant extracellular matrix for cell growth, this novel product should aid in the study of organoids and spheroid.

Global Organoids And Spheroids Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Type, Method, End-user, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Organoids Type
  • Spheroids Type

By Method:

  • Extracellular Matrix Scaffold Method
  • Spinning Bioreactor Method
  • Hanging Drop Method
  • Low Adherent Culture Plate Method
  • Magnetic Levitation Method

By End-user:

  • Biotechnology and Pharmaceutical Industry
  • Academic and Research Institutes
  • Hospitals and Diagnostic Centers

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

  • 1.1.Market Snapshot
  • 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1.Organoids and Spheroids Market, by Region, 2020-2030 (USD Million)
    • 1.2.2.Organoids and Spheroids Market, by Type, 2020-2030 (USD Million)
    • 1.2.3.Organoids and Spheroids Market, by Method, 2020-2030 (USD Million)
    • 1.2.4.Organoids and Spheroids Market, by End-user, 2020-2030 (USD Million)
  • 1.3.Key Trends
  • 1.4.Estimation Methodology
  • 1.5.Research Assumption

Chapter 2.Global Organoids and Spheroids Market Definition and Scope

  • 2.1.Objective of the Study
  • 2.2.Market Definition & Scope
    • 2.2.1.Industry Evolution
    • 2.2.2.Scope of the Study
  • 2.3.Years Considered for the Study
  • 2.4.Currency Conversion Rates

Chapter 3.Global Organoids and Spheroids Market Dynamics

  • 3.1.Organoids and Spheroids Market Impact Analysis (2020-2030)
    • 3.1.1.Market Drivers
      • 3.1.1.1.Increasing prevalence of chronic diseases
      • 3.1.1.2.Rising adoption of personalized medicines
    • 3.1.2.Market Challenges
      • 3.1.2.1.Challenges associated with 3D cell culturing
      • 3.1.2.2.Ethical issues associated with organoid & spheroid cultures
    • 3.1.3.Market Opportunities
      • 3.1.3.1.Growing field of cell therapy and tissue engineering
      • 3.1.3.2.Increasing technological advancements in 3D spheroid technologies

Chapter 4.Global Organoids and Spheroids Market Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
  • 4.2.Porter's 5 Force Impact Analysis
  • 4.3.PEST Analysis
    • 4.3.1.Political
    • 4.3.2.Economical
    • 4.3.3.Social
    • 4.3.4.Technological
    • 4.3.5.Environmental
    • 4.3.6.Legal
  • 4.4.Top investment opportunity
  • 4.5.Top winning strategies
  • 4.6.COVID-19 Impact Analysis
  • 4.7.Disruptive Trends
  • 4.8.Industry Expert Perspective
  • 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Organoids and Spheroids Market, by Type

  • 5.1.Market Snapshot
  • 5.2.Global Organoids and Spheroids Market by Type, Performance - Potential Analysis
  • 5.3.Global Organoids and Spheroids Market Estimates & Forecasts by Type 2020-2030 (USD Million)
  • 5.4.Organoids and Spheroids Market, Sub Segment Analysis
    • 5.4.1.Organoids Type
    • 5.4.2.Spheroids Type

Chapter 6.Global Organoids and Spheroids Market, by Method

  • 6.1.Market Snapshot
  • 6.2.Global Organoids and Spheroids Market by Method, Performance - Potential Analysis
  • 6.3.Global Organoids and Spheroids Market Estimates & Forecasts by Method 2020-2030 (USD Million)
  • 6.4.Organoids and Spheroids Market, Sub Segment Analysis
    • 6.4.1.Extracellular Matrix scaffold Method
    • 6.4.2.Spinning Bioreactor method
    • 6.4.3.Hanging Drop method
    • 6.4.4.Low adherent Culture plate method
    • 6.4.5.Magnetic leviation Method

Chapter 7.Organoids and Spheroids Market, by End-user

  • 7.1.Market Snapshot
  • 7.2.Global Organoids and Spheroids Market by End-user, Performance - Potential Analysis
  • 7.3.Global Organoids and Spheroids Market Estimates & Forecasts by End-user 2020-2030 (USD Million)
  • 7.4.Organoids and Spheroids Market, Sub Segment Analysis
    • 7.4.1.Biotechnology and Pharmaceutical Industry
    • 7.4.2.Academic and Research Institutes
    • 7.4.3.Hospitals and Diagnostic Centers

Chapter 8.Global Organoids and Spheroids Market, Regional Analysis

  • 8.1.Top Leading Countries
  • 8.2.Top Emerging Countries
  • 8.3.Organoids and Spheroids Market, Regional Market Snapshot
  • 8.4.North America Organoids and Spheroids Market
    • 8.4.1.U.S. Organoids and Spheroids Market
      • 8.4.1.1.Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2.Method breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3.End-user breakdown estimates & forecasts, 2020-2030
    • 8.4.2.Canada Organoids and Spheroids Market
  • 8.5.Europe Organoids and Spheroids Market Snapshot
    • 8.5.1.U.K. Organoids and Spheroids Market
    • 8.5.2.Germany Organoids and Spheroids Market
    • 8.5.3.France Organoids and Spheroids Market
    • 8.5.4.Spain Organoids and Spheroids Market
    • 8.5.5.Italy Organoids and Spheroids Market
    • 8.5.6.Rest of Europe Organoids and Spheroids Market
  • 8.6.Asia-Pacific Organoids and Spheroids Market Snapshot
    • 8.6.1.China Organoids and Spheroids Market
    • 8.6.2.India Organoids and Spheroids Market
    • 8.6.3.Japan Organoids and Spheroids Market
    • 8.6.4.Australia Organoids and Spheroids Market
    • 8.6.5.South Korea Organoids and Spheroids Market
    • 8.6.6.Rest of Asia Pacific Organoids and Spheroids Market
  • 8.7.Latin America Organoids and Spheroids Market Snapshot
    • 8.7.1.Brazil Organoids and Spheroids Market
    • 8.7.2.Mexico Organoids and Spheroids Market
  • 8.8.Middle East & Africa Organoids and Spheroids Market
    • 8.8.1.Saudi Arabia Organoids and Spheroids Market
    • 8.8.2.South Africa Organoids and Spheroids Market
    • 8.8.3.Rest of Middle East & Africa Organoids and Spheroids Market

Chapter 9.Competitive Intelligence

  • 9.1.Key Company SWOT Analysis
  • 9.2.Top Market Strategies
  • 9.3.Company Profiles
    • 9.3.1.InSphero AG
      • 9.3.1.1.Key Information
      • 9.3.1.2.Overview
      • 9.3.1.3.Financial (Subject to Data Availability)
      • 9.3.1.4.Product Summary
      • 9.3.1.5.Recent Developments
    • 9.3.2.Lonza Group
    • 9.3.3.PeproTech Inc
    • 9.3.4.Greiner AG
    • 9.3.5.STEMCELL Technologies Inc
    • 9.3.6.Corning Inc
    • 9.3.7.Cellesce Ltd
    • 9.3.8.Perkin Elmer Inc
    • 9.3.9.Merck KGaA
    • 9.3.10.Thermofisher Scientific Inc

Chapter 10.Research Process

  • 10.1.Research Process
    • 10.1.1.Data Mining
    • 10.1.2.Analysis
    • 10.1.3.Market Estimation
    • 10.1.4.Validation
    • 10.1.5.Publishing
  • 10.2.Research Attributes
  • 10.3.Research Assumption